HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Chen Selected Research

tetrandrine

9/2011The potential of tetrandrine as a protective agent for ischemic stroke.
9/2010The Potential of Tetrandrine against Gliomas.
1/2010Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice.
11/2009Tetrandrine ameliorated reperfusion injury of small bowel transplantation.
8/2009Effects of tetrandrine plus radiation on neuroblastoma cells.
5/2009Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats.
2/2009Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Chen Research Topics

Disease

229Neoplasms (Cancer)
10/2022 - 02/2002
46Breast Neoplasms (Breast Cancer)
01/2022 - 07/2010
30Infections
11/2022 - 12/2009
30Neoplasm Metastasis (Metastasis)
06/2022 - 09/2011
29Inflammation (Inflammations)
12/2022 - 12/2003
23Erectile Dysfunction
11/2019 - 10/2005
20Glioma (Gliomas)
09/2020 - 03/2004
19Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2008
18Esophageal Squamous Cell Carcinoma
01/2022 - 12/2013
15Carcinoma (Carcinomatosis)
01/2022 - 06/2003
14Hepatocellular Carcinoma (Hepatoma)
12/2022 - 10/2009
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 08/2011
12Hemorrhage
11/2022 - 02/2010
12Carcinogenesis
01/2022 - 04/2014
12Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 12/2013
12Neuroblastoma
08/2021 - 09/2002
11Body Weight (Weight, Body)
01/2022 - 05/2004
11Insulin Resistance
11/2021 - 12/2008
10Stomach Neoplasms (Stomach Cancer)
05/2022 - 01/2015
9Hypertension (High Blood Pressure)
01/2022 - 04/2010
9Fibrosis (Cirrhosis)
12/2021 - 12/2003
9Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 01/2017
8Alzheimer Disease (Alzheimer's Disease)
04/2022 - 01/2019
8Hypoxia (Hypoxemia)
04/2022 - 03/2014
8Diabetes Mellitus
02/2021 - 03/2007
8Necrosis
01/2020 - 12/2003
7Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 04/2012
7Wounds and Injuries (Trauma)
11/2021 - 03/2015
7Reperfusion Injury
01/2020 - 03/2002
7Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2018 - 06/2009
6Obesity
10/2022 - 12/2008
6Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 09/2013
6Stroke (Strokes)
04/2022 - 07/2004
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 07/2012
6Lung Neoplasms (Lung Cancer)
09/2021 - 05/2016
6Leukemia
01/2021 - 06/2005
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 05/2010
6Nasopharyngeal Carcinoma
11/2020 - 05/2005
6Colonic Neoplasms (Colon Cancer)
01/2018 - 11/2006

Drug/Important Bio-Agent (IBA)

68Proteins (Proteins, Gene)FDA Link
09/2022 - 05/2005
48Pharmaceutical PreparationsIBA
09/2022 - 09/2006
34MicroRNAs (MicroRNA)IBA
01/2022 - 08/2009
33Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2014
21Therapeutic UsesIBA
05/2022 - 11/2002
19Doxorubicin (Adriamycin)FDA LinkGeneric
09/2021 - 06/2005
16Insulin (Novolin)FDA Link
10/2022 - 10/2009
16Biological ProductsIBA
09/2022 - 09/2011
16Glucose (Dextrose)FDA LinkGeneric
08/2021 - 08/2010
16Paclitaxel (Taxol)FDA LinkGeneric
12/2020 - 09/2013
14Messenger RNA (mRNA)IBA
01/2022 - 06/2003
13Cisplatin (Platino)FDA LinkGeneric
01/2022 - 10/2012
13RNA (Ribonucleic Acid)IBA
01/2022 - 03/2013
12Peptides (Polypeptides)IBA
04/2022 - 04/2010
12VaccinesIBA
01/2022 - 02/2005
12Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 09/2010
11CytokinesIBA
10/2022 - 11/2002
10Long Noncoding RNAIBA
01/2022 - 01/2015
10LipidsIBA
01/2022 - 02/2007
9EnzymesIBA
12/2022 - 05/2005
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 03/2004
9AntigensIBA
01/2022 - 05/2005
9Phosphotransferases (Kinase)IBA
08/2021 - 04/2013
9Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2020 - 10/2012
8Interleukin-6 (Interleukin 6)IBA
06/2022 - 09/2011
8Circular RNAIBA
01/2022 - 01/2017
8CollagenIBA
11/2021 - 04/2010
8CateninsIBA
01/2021 - 03/2014
7CholesterolIBA
10/2022 - 02/2007
7InflammasomesIBA
01/2022 - 01/2018
7Antiviral Agents (Antivirals)IBA
01/2022 - 05/2007
7Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2014
7HydrogelsIBA
01/2022 - 11/2016
7Membrane Proteins (Integral Membrane Proteins)IBA
01/2020 - 05/2005
7BenzylisoquinolinesIBA
09/2011 - 02/2009
7tetrandrineIBA
09/2011 - 02/2009
7AlkaloidsIBA
09/2011 - 02/2009
6Triglycerides (Triacylglycerol)IBA
10/2022 - 12/2010
6Adenosine Triphosphate (ATP)IBA
05/2022 - 04/2012
6AntioxidantsIBA
04/2022 - 06/2012
6Indicators and Reagents (Reagents)IBA
01/2022 - 02/2014
6Protein Isoforms (Isoforms)IBA
01/2022 - 10/2009
6Polysaccharides (Glycans)IBA
12/2021 - 01/2016
6Sirtuin 3IBA
11/2021 - 01/2018
6GoldIBA
07/2021 - 04/2016
6Caspase 3 (Caspase-3)IBA
02/2021 - 05/2004
6Streptozocin (Streptozotocin)FDA Link
02/2021 - 03/2007
6DNA (Deoxyribonucleic Acid)IBA
01/2020 - 02/2002
6TensinsIBA
01/2020 - 10/2012
6Fluorouracil (Carac)FDA LinkGeneric
10/2019 - 12/2016
6ResveratrolIBA
04/2019 - 03/2004
6Cancer VaccinesIBA
03/2014 - 09/2002

Therapy/Procedure

82Therapeutics
05/2022 - 02/2002
32Drug Therapy (Chemotherapy)
02/2022 - 06/2003
20Radiotherapy
01/2021 - 05/2006
16Immunotherapy
10/2022 - 11/2002
13Transplantation
01/2021 - 11/2009
9Injections
11/2022 - 01/2018
9Chemoradiotherapy
01/2021 - 07/2008
8Aftercare (After-Treatment)
07/2022 - 12/2011
7Length of Stay
05/2022 - 05/2004